Frailty has become a highly relevant geriatric syndrome in older people with diabetes since it constitutes…
Continue ReadingTag: secondary
Evaluating Variations in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE Study
Background Coronary artery disease (CAD) affected >315 million people worldwide in 2022.1 Individuals with CAD have…
Continue Reading
PURE: Secondary Prevention Medications For CVD Underused Globally
Secondary prevention medications for cardiovascular diseases are underused globally and additional strategies to increase their use…
Continue Reading
‘Concerningly Low’ Use of CVD Meds for Secondary Prevention
TOPLINE: Among patients with cardiovascular disease (CVD) in 17 countries, many receive no medication for secondary…
Continue Reading
A smartphone-guided secondary prevention digital health application reduces systolic blood pressure in patients with chronic coronary syndrome and insufficient blood pressure control
Background Coronary artery disease (CAD) is the manifestation of atherosclerosis in the coronary arteries. The pathogenesis…
Continue Reading
Use of Secondary CVD Prevention Meds Still Meager Worldwide
An analysis of the PURE study shows some gains but “little to no improvement in most…
Continue Reading